The Retinopathy of Prematurity Market is poised for transformative growth, with projections indicating an increase from USD 2.51 billion in 2025 to USD 4.375 billion by 2035. This growth reflects a significant opportunity for stakeholders, driven by an evolving understanding of prematurity and its implications for eye health. The anticipated CAGR of 5.71% underscores a robust expansion in the...